EUVIMEDEUVIMED entdecken
Querschnittstudie

Clinical, Epidemiological, and Demographic Predictors of Laboratory-Confirmed Mpox among Rash-Presenting Patients: A Retrospective Cross-Sectional Study

Alaa Jadidi, Ahmed Alzahrani, Mohammed Kareem, Maimona Flimban, Bayan Alghamdi, Duaa Batyah, Lamees Omran, Noran Mohammed

Saudi Journal of Public Health · 15.07.2026 · 1 (3)

DOI: 10.64819/art000015 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Saudi Journal of Public Health, online erschienen am 15.07.2026. Verfasst von Alaa Jadidi und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Monkeypox (mpox) is a zoonotic viral disease first identified in monkeys in 1958 and later in humans in 1970. Historically endemic in Central and West Africa, mpox gained global significance following the 2022 outbreak, which resulted in widespread transmission across multiple countries. The disease commonly presents with fever, fatigue, and a progressive rash, but its clinical features often overlap with other rash-associated conditions, complicating diagnosis. Understanding demographic and epidemiologic predictors is therefore essential to support early case identification and public health response. This study aimed to describe the clinical, epidemiological, and demographic characteristics of patients with laboratory-confirmed mpox and to identify independent predictors of mpox positivity among rash-presenting patients in Jeddah, Saudi Arabia.

Methods

A retrospective cross-sectional analysis was conducted using data from the national Health Electronic Surveillance Network (HESN). All patients presenting with rash who underwent mpox PCR testing between 2022 and 2025 across governmental and private hospitals in Jeddah were included. Demographic variables and clinical symptoms were analyzed. Group comparisons were performed using the Mann–Whitney U and Chi-square tests. Multivariable logistic regression was used to identify independent predictors of mpox positivity, with model performance assessed using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity.

Results

A total of 443 patients were included, of whom 147 (33.2%) were mpox-positive. Mpox-positive patients had a significantly higher median age compared with mpox-negative patients (35 vs. 31 years, p < 0.001). Males constituted the majority of confirmed cases. In multivariable analysis, older age and male gender were independently associated with mpox positivity (p < 0.05), while clinical symptoms were not significant predictors. The final model demonstrated moderate discriminative ability (AUC = 0.670), with high sensitivity (0.949) and low specificity (0.041).

Conclusion

Mpox was confirmed in one-third of patients presenting with a rash in Jeddah. Demographic factors, particularly age and gender, were more informative than clinical symptoms, supporting the role of PCR testing and demographic-based screening in mpox surveillance and control. However, the low specificity of the applied predictive model warrants further research to identify additional factors associated with the risk of mpox.

Zitieren

APA

Jadidi, A., Alzahrani, A., Kareem, M., Flimban, M., Alghamdi, B., Batyah, D., Omran, L., & Mohammed, N. (2026). Clinical, Epidemiological, and Demographic Predictors of Laboratory-Confirmed Mpox among Rash-Presenting Patients: A Retrospective Cross-Sectional Study. Saudi Journal of Public Health, 1(3). https://doi.org/10.64819/art000015

Vancouver

Jadidi A, Alzahrani A, Kareem M, Flimban M, Alghamdi B, Batyah D, et al. Clinical, Epidemiological, and Demographic Predictors of Laboratory-Confirmed Mpox among Rash-Presenting Patients: A Retrospective Cross-Sectional Study. Saudi Journal of Public Health. 2026;1(3). doi:10.64819/art000015

BibTeX
@article{Jadidi2026,
  author = {Jadidi, Alaa and Alzahrani, Ahmed and Kareem, Mohammed and Flimban, Maimona and Alghamdi, Bayan and Batyah, Duaa and Omran, Lamees and Mohammed, Noran},
  title = {Clinical, Epidemiological, and Demographic Predictors of Laboratory-Confirmed Mpox among Rash-Presenting Patients: A Retrospective Cross-Sectional Study},
  journal = {Saudi Journal of Public Health},
  year = {2026},
  volume = {1},
  number = {3},
  doi = {10.64819/art000015}
}
Kostenlos starten →